Safety of extraovular catheter insertion for second-trimester abortion

Obstetrics and Gynecology

Volumn 96, Issue 4, 2000, Pages 529-532

  Ben Arie, Alon ^a   Hazan, Ynon ^a   Goldchmit, Reinaldo ^a   Hagay, Zion ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN;

ABORTION; ADULT; ARTICLE; CATHETERIZATION; CURETTAGE; FEMALE; GENETIC SCREENING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROPHYLAXIS; SAFETY; SECOND TRIMESTER PREGNANCY; TREATMENT OUTCOME; UTERUS BLEEDING;

ABORTION, INDUCED; ADOLESCENT; ADULT; CATHETERIZATION; DINOPROSTONE; FEMALE; HUMAN; MIDDLE AGE; OXYTOCICS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SEPSIS SYNDROME;

EID: 0033833731     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00960-1     Document Type: Article

References (20)

1. 2α. Lancet. 1:1970;157-159.
2. Roth-Brandel U., Bygdeman M., Wiqvist N., Bergstrom S. Prostaglandins for induction of therapeutic abortion. Lancet. 1:1970;190-191.
3. 2α for midtrimester abortion. Am J Obstet Gynecol. 120:1974;273-280.
4. Embrey M.P., Hillier K. Therapeutic abortion by intrauterine instillation of prostaglandins. BMJ. 1:1971;588-590.
5. 2α instillation for second-trimester pregnancy termination. Isr J Med Sci. 21:1985;935-939.
6. Young L.S. Sepsis syndrome. Mandell G.L., Bennet J.E., Dolin R. Principles and practice of infectious diseases. 1995;690-695 Churchill Livingstone, New York.
7. Bone R.C. Toward an epidemiology and natural history of SIRS (systemic infammatory response syndrome). JAMA. 268:1992;3452-3455.
8. American College of Obstetricians and Gynecologists. Methods of midtrimester abortion. Washington, DC: American College of Obstetricians and Gynecologists, 1987:1-4.
9. Rayburn W.F., Laferla J.J. Mid-gestational abortion for medical or genetic indications. Clin Obstet Gynecol. 13:1986;71-82.
10. Castadot R.G. Pregnancy termination Techniques, risks, and complications and their management . Fertil Steril. 45:1986;5-17.
11. Grimes D.A., Schulz K.F., Cates W., Tyler C.W. Midtrimester abortion by dilatation and evacuation A safe and practical alternative . N Engl J Med. 296:1977;1141-1145.
12. 2α A randomized clinical trial . Am J Obstet Gynecol. 137:1980;785-790.
13. Shulman L.P., Ling F.W., Meyers C.M., Shanklin D.R., Simpson J.L., Elias S. Dilatation and evacuation for second-trimester genetic pregnancy termination. Obstet Gynecol. 75:1990;1037-1040.
14. 2α . Contraception. 47:1993;475-481.
15. 2α for pregnancy termination in the second and early third trimesters of pregnancy. J Reprod Med. 42:1997;235-238.
16. 2 administration . Int J Gynaecol Obstet. 35:1991;337-340.
17. Abramovici H., Bornstein J., Ben David Y., Yishai D., Rofe A., Atad J. Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases. J Reprod Med. 40:1995;56-62.
18. 2α. Int J Gynaecol Obstet. 14:1976;439-444.
19. Jasnosz K.M., Shakir A.M., Perper J.A. Fatal Clostridium perfringens and Escherichia coli sepsis following urea-instillation abortion. Am J Forensic Med Pathol. 4:1993;151-154.
20. 2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy. Adv Contracep. 9:1993;331-333.